Treatment group | Percentage time pH<4 in 24 h | Percentage time pH<4, diurnal | Percentage time pH<4, nocturnal |
Group 1, n = 12 | |||
Placebo | 14.9 | 9.5 | 22.7 |
ADX10059, 50 mg | 15.1 | 12.8 | 18.9 |
Estimate change from baseline | 2.71 | 4.75 | 0.19 |
95% Confidence interval | −2.05 to 7.48 | 0.14 to 9.37 | −5.88 to 6.26 |
p Value | NS | 0.0442* | NS |
Group 2, n = 11 | |||
Placebo | 7.2 | 5.2 | 9.7 |
ADX10059, 250 mg | 3.6 | 3.4 | 3.7 |
Estimate change from baseline | −6.41 | −3.41 | −10.37 |
95% Confidence interval | −11.4 to −1.42 | −8.24 to 1.42 | −16.73 to −4.01 |
p Value | 0.0144 | NS | 0.0028 |
*Increased compared with placebo.
NS, not significant.